Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery. 2021

Manish Kumar Tripathi, and Abhigyan Nath, and Tej P Singh, and A S Ethayathulla, and Punit Kaur
Department of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029, India.

The accumulation of massive data in the plethora of Cheminformatics databases has made the role of big data and artificial intelligence (AI) indispensable in drug design. This has necessitated the development of newer algorithms and architectures to mine these databases and fulfil the specific needs of various drug discovery processes such as virtual drug screening, de novo molecule design and discovery in this big data era. The development of deep learning neural networks and their variants with the corresponding increase in chemical data has resulted in a paradigm shift in information mining pertaining to the chemical space. The present review summarizes the role of big data and AI techniques currently being implemented to satisfy the ever-increasing research demands in drug discovery pipelines.

UI MeSH Term Description Entries
D000069550 Machine Learning A type of ARTIFICIAL INTELLIGENCE that enable COMPUTERS to independently initiate and execute LEARNING when exposed to new data. Transfer Learning,Learning, Machine,Learning, Transfer
D000077321 Deep Learning Supervised or unsupervised machine learning methods that use multiple layers of data representations generated by nonlinear transformations, instead of individual task-specific ALGORITHMS, to build and train neural network models. Hierarchical Learning,Learning, Deep,Learning, Hierarchical
D000077558 Big Data Extremely large amounts of data which require rapid and often complex computational analyses to reveal patterns, trends, and associations, relating to various facets of human and non-human entities.
D000465 Algorithms A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task. Algorithm
D001185 Artificial Intelligence Theory and development of COMPUTER SYSTEMS which perform tasks that normally require human intelligence. Such tasks may include speech recognition, LEARNING; VISUAL PERCEPTION; MATHEMATICAL COMPUTING; reasoning, PROBLEM SOLVING, DECISION-MAKING, and translation of language. AI (Artificial Intelligence),Computer Reasoning,Computer Vision Systems,Knowledge Acquisition (Computer),Knowledge Representation (Computer),Machine Intelligence,Computational Intelligence,Acquisition, Knowledge (Computer),Computer Vision System,Intelligence, Artificial,Intelligence, Computational,Intelligence, Machine,Knowledge Representations (Computer),Reasoning, Computer,Representation, Knowledge (Computer),System, Computer Vision,Systems, Computer Vision,Vision System, Computer,Vision Systems, Computer
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D016208 Databases, Factual Extensive collections, reputedly complete, of facts and data garnered from material of a specialized subject area and made available for analysis and application. The collection can be automated by various contemporary methods for retrieval. The concept should be differentiated from DATABASES, BIBLIOGRAPHIC which is restricted to collections of bibliographic references. Databanks, Factual,Data Banks, Factual,Data Bases, Factual,Data Bank, Factual,Data Base, Factual,Databank, Factual,Database, Factual,Factual Data Bank,Factual Data Banks,Factual Data Base,Factual Data Bases,Factual Databank,Factual Databanks,Factual Database,Factual Databases
D055808 Drug Discovery The process of finding chemicals for potential therapeutic use. Drug Prospecting,Discovery, Drug,Prospecting, Drug
D057188 Workflow Description of pattern of recurrent functions or procedures frequently found in organizational processes, such as notification, decision, and action. Work Flow,Work Flows,Workflows

Related Publications

Manish Kumar Tripathi, and Abhigyan Nath, and Tej P Singh, and A S Ethayathulla, and Punit Kaur
December 2019, Stroke and vascular neurology,
Manish Kumar Tripathi, and Abhigyan Nath, and Tej P Singh, and A S Ethayathulla, and Punit Kaur
January 2020, Annual review of pharmacology and toxicology,
Manish Kumar Tripathi, and Abhigyan Nath, and Tej P Singh, and A S Ethayathulla, and Punit Kaur
February 2022, Biochemical Society transactions,
Manish Kumar Tripathi, and Abhigyan Nath, and Tej P Singh, and A S Ethayathulla, and Punit Kaur
February 2023, Pharmaceuticals (Basel, Switzerland),
Manish Kumar Tripathi, and Abhigyan Nath, and Tej P Singh, and A S Ethayathulla, and Punit Kaur
January 2020, Computational and structural biotechnology journal,
Manish Kumar Tripathi, and Abhigyan Nath, and Tej P Singh, and A S Ethayathulla, and Punit Kaur
January 2021, Current drug targets,
Manish Kumar Tripathi, and Abhigyan Nath, and Tej P Singh, and A S Ethayathulla, and Punit Kaur
November 2019, Expert opinion on drug discovery,
Manish Kumar Tripathi, and Abhigyan Nath, and Tej P Singh, and A S Ethayathulla, and Punit Kaur
December 2023, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Manish Kumar Tripathi, and Abhigyan Nath, and Tej P Singh, and A S Ethayathulla, and Punit Kaur
May 2019, Nature reviews. Cardiology,
Manish Kumar Tripathi, and Abhigyan Nath, and Tej P Singh, and A S Ethayathulla, and Punit Kaur
August 2018, Der Nervenarzt,
Copied contents to your clipboard!